1. Snake venoms are complex mixtures of pharmacologically active peptides and proteins.
INTRODUCTION
Snake venoms are complex mixtures of pharmacologically active proteins and polypeptides. Some of these proteins exhibit lethal and debilitating effects as a consequence of neurotoxic, cardiotoxic and tissue necrotizing effects, whereas others induce various pharmacological effects, but are of a lower order of toxicity. All these protein toxins attack various physiological processes at specific sites. The study of snake venoms and toxins by scientists with diverse backgrounds and expertise has focused on one or more of the following objectives: (i) to determine the mode and mechanism of action of the toxins; (ii) to find ways and means to neutralize the toxicity and adverse effects of snake bites; (iii) to develop specific research tools that are useful in understanding normal physiological processes at both cellular and molecular levels; and (iv) to develop prototypes of pharmaceutical agents based on the structure of toxins. Important lessons can be learnt, particularly from the latter two objectives, as to how simple molecular templates have been used in nature to design a wide arsenal of proteins that exhibit diverse (toxic) functions.
A large number of protein toxins has been purified and characterized from snake venoms. [1] [2] [3] [4] [5] Many early efforts were directed towards the isolation and characterization of either proteins that are found in abundance or the most toxic components of the venom. The advent of more sophisticated purification techniques has resulted in the study of more interesting proteins found in smaller quantities. It is now known that snake venoms contain over 100 protein toxins. However, these toxins belong to a very small number of superfamilies of proteins. Some of the wellrecognized families of venom proteins are: (i) three-finger toxin family; (ii) proteinase inhibitor family; (iii) lectin family; (iv) phospholipase A 2 (PLA 2 ) family; (v) serine proteinase family; and (vi) metalloproteinase family. The members in a single family show remarkable similarities in their primary, secondary and tertiary structures. At times, however, they differ from each other in their biological targeting and, hence, their pharmacological effects. That is, each family of protein toxins has a similar molecular scaffold but exhibits multiple functions. Thus, structurefunction relationships and the mechanisms of action of snake venom proteins are intriguing and pose exciting challenges to scientists. So far, we have understood structure-function relationships of only a small number of toxins in some of these families. The theme of 'molecular moulds with multiple missions' is well illustrated by the structure-function relationships of the family of three-finger toxins, which is concisely covered in the present review.
THREE-FINGER TOXIN FAMILY
This is a family of non-enzymatic polypeptides containing 60-74 amino acid residues. 2, 6 This family of proteins is found only in the venoms of elapids (cobras, kraits and mambas) and hydrophid (sea snakes) and not those of vipers and crotalids (rattlesnakes). Similar to other snake venom proteins, three-finger toxins are also rich in disulphide bonds. They contain four or five disulphide bridges, of which four are conserved in all members. 2 Consequently, all proteins of this family show a similar pattern of protein folding: three ␤ -stranded loops extending from a central core containing the RM Kini four conserved disulphide bridges. 7, 8 Because of this appearance, this family of proteins is called the three-finger toxin family.
DIVERSITY IN BIOLOGICAL PROPERTIES
Despite the overall similarity in structure, these polypeptides differ from each other in their biological activities. Members of this family include ␣ -neurotoxins, which antagonize muscle nicotinic acetylcholine receptors (nAChR), [8] [9] -bungarotoxins, which recognize neuronal nicotinic receptors, 10 muscarinic toxins with selectivity towards distinct types of muscarinic receptors, 11 fasciculins that inhibit acetylcholinesterase, 2 calciseptins that block the L-type calcium channels, 12, 13 cardiotoxins (cytotoxins) that exert their toxicity by forming pores in cell membranes 17 and dendroaspins, which are antagonists of various cell-adhesion processes. 15 Interestingly, the three-fingered fold is not restricted to snake venom toxins because several other non-venom proteins and polypeptides also belong to this superfamily of proteins. [16] [17] [18] [19] [20] Neurotoxins A large number of members of this family of toxins are neurotoxins. These neurotoxins interfere with cholinergic transmission at various post-synaptic sites in the peripheral and central nervous systems. 9 Based on their receptor selectivity, they can be broadly classified as curaremimetic or ␣ -neurotoxins, -toxins and muscarinic toxins that target muscle nAChR, neuronal nAChR and various subtypes of muscarinic receptors, respectively. Over the years, curaremimetic toxins have contributed significantly to isolation and characterization of muscle ( ␣ 1) AChR, making it one of the best characterized receptors today. 21 Similarly, muscarinic and -toxins have also helped us understand molecular details of various muscarinic and neuronal AChR subtypes and their role in neurotransmission.
Curaremimetic toxins
Curaremimetic toxins (or ␣ -neurotoxins) bind to muscle ( ␣ 1) nAChR and inhibit acetylcholine from binding to the receptor, . Note all these 'sibling' toxins share a similar structural fold; the core at the top of the molecules contains all four conserved disulphide bridges and three ␤ -sheeted 'fingers' start from the core. These ␤ -sheeted loops are numbered right to left as loop I, II and III, respectively. Some toxins, such as ␣ -bungarotoxin (b) and -bungarotoxin (d) have the fifth disulphide bridge in loop II. In contrast, candoxin (e) has the fifth disulphide bridge in loop I. However, these toxins differ from each other in their biological activities. thereby impairing neuromuscular transmission. 1, 9 In this respect, they imitate the effects of the alkaloid curare (hence the name). They are further classified as short-chain neurotoxins (60-62 amino acid residues and four disulphides) and long-chain neurotoxins (66-74 amino acid residues and five disulphides). Despite their difference in size, they share similarity in structural folding (Fig. 1a,b) . However, the presence of a fifth unconserved disulphide bridge at the tip of the second loop, as well as a longer carboxy terminal tail, constitute two significant differences seen in long-chain neurotoxins. 2, 7, 8 These differences notwithstanding, both long-and short-chain neurotoxins bind to the same site on the muscle nAChR with equal affinity, competing with each other for binding. 2 In addition, long-chain but not short-chain neurotoxins bind to neuronal ␣ 7 nAChR with high affinity. [22] [23] [24] Thus, the longand short-chain neurotoxins appear to have differences in their targeting and this subtle difference has been correlated to the presence of the fifth disulphide in the second loop. 22 
Muscarinic toxins
Muscarinic toxins bind specifically and with high selectivity to various subsets of muscarinic AChR. 25 These toxins are structurally related to short-chain neurotoxins (Fig. 1c) . However, unlike ␣ -neurotoxins, some muscarinic toxins act as agonists, whereas others act as antagonists on muscarinic AChR.
-Toxins
-Toxins bind specifically to neuronal ( ␣ 3 ␤ 4) nAChR. 10 Like longchain ␣ -neurotoxins, -toxins have five disulphide bridges, with the fifth disulphide bridge located in the second loop (Fig. 1d) . However, unlike any other member of the three-finger toxin family, -toxins exist as dimmers. 10 Short-and long-chain neurotoxins have poor affinity for neuronal ( ␣ 3 ␤ 4) nAChR. Similarly, -toxins do not bind to ␣ 1 nAChR.
Other toxins
Other toxins with a unique cysteine scaffold different from those of short-and long-chain neurotoxins have recently been characterized. These toxins, in addition to the four conserved disulphide bridges, have a fifth disulphide bond in the first loop. 8, [26] [27] [28] Based on their toxicity, they were classified as weak neurotoxins. 29, 30 One of the members, WTX from cobra ( Naja kaouthia ) venom, has been shown to bind to both muscle ( ␣ 1) and neuronal ( ␣ 7) AChR, albeit at micromolar concentrations. 30 In contrast, candoxin from the venom of the Malayan krait ( Bungarus candidus ; Fig. 1e ) binds to muscle ( ␣ 1) and neuronal ( ␣ 7) AChR with nanomolar affinity. Interestingly, its binding to muscle ( ␣ 1) nAChR is easily reversible, in contrast with its binding to neuronal ␣ 7 nAChR, which is only partially reversible. 31 
Acetylcholinesterase inhibitors
This class of three-finger toxins interferes with neuromuscular transmission by inhibiting the enzyme acetylcholinesterase (AChE) present at the neuromuscular junction. Thus, these toxins induce fasciculation in muscle due to accumulation of acetylcholine at the synapse and are aptly named as fasciculins. 2 Fasciculins have been isolated from mamba ( Dendroaspis ) snake venoms. They are structurally similar to short-chain neurotoxins (Fig. 1f) . They bind to the peripheral site of AChE and block the entry of acetylcholine into the active site of the enzyme, thereby preventing its breakdown. 32 
Cardiotoxins
This group of polypeptides is found only in cobra venoms and is the second-largest group of three-finger toxins. Structurally, cardiotoxins resemble short-chain neurotoxins: they have 59-62 amino acid residues and four conserved disulphide bonds (Fig. 1g) . 6, 14 At lower concentrations, cardiotoxins increase heart rate and, at higher concentrations, kill the animal by cardiac arrest. 6 However, the protein target of cardiotoxins in cardiac myocytes has not yet been identified. A large number of this group of toxins also exhibits general cytolytic effects (i.e. form ion pores in the lipid membranes) and, therefore, they are also referred to as cytolysins. 6, 33 In addition, poorly characterized cardiotoxin-like basic polypeptides (CLBP) have also been described. 34, 35 These polypeptides do not act as cardiotoxins or cytotoxins, their nomenclature notwithstanding, and may have entirely different biological activity.
Other three-finger toxins
A group of three-finger toxins, such as calciseptine and FS2 (Fig. 1h) , specifically block L-type calcium channels. 12, 13 These polypeptides are structurally similar to short-chain neurotoxins, with 60 amino acid residues and four conserved disulphide bridges. They bind to the 1,4-dihydropyridine binding site of the L-type calcium channels and physically block the calcium currents. 36 Another toxin, named dendroaspin (or mambin) and isolated from Dendroaspis jamesoni venom, is a potent inhibitor of platelet aggregation. 15 This protein is also structurally similar to shortchain neurotoxins, with 60 amino acid residues and four conserved disulphide bridges (Fig. 1i) . Dendroaspin contains an Arg-Gly-Asp tripeptide sequence, which is involved in the adhesive function of several proteins. As expected, dendroaspin interferes with the interaction between fibrinogen and its receptor glycoprotein IIB-IIIa (␣IIb␤3) complex and, hence, platelet aggregation. In addition, there are several other three-finger toxins, including synergistic toxins and angusticeps toxins, 2 that have not been well characterized functionally and, hence, will not be dealt in any further detail in the present review.
FUNCTIONAL SITES
As is clearly evident, three-finger toxins share similar protein folds and three-dimensional structures, but exhibit diverse biological properties. Therefore, understanding their structure-function relationships and identifying their functional sites is a subtle, complicated and challenging task. Using a combination of theoretical and experimental approaches, we and others have successfully identified some of the functional sites in a number of three-finger toxins.
Neurotoxins
Earlier studies on neurotoxins were based on the chemical modification of specific amino acid residues from which some critical residues have been identified to be important for binding to the (Fig. 2 ). These studies reveal that both short-and long-chain neurotoxins use a number of structurally equivalent residues, including Lys23/ Lys27, Asp27/Asp31, Arg33/Arg33 and Lys49/Lys4, as well as Trp25/Trp29 and Phe29/Phe32, in binding to Torpedo receptor. In addition, the tip of the first loop in erabutoxin a and, in contrast, the carboxy terminal tail in ␣-cobratoxin also play important binding roles. Antil-Delbeke et al. 24 and Antil et al. 39 have identified the residues in ␣-cobratoxin that are involved in the recognition of and binding to neuronal ␣7 nAChR. Interestingly, ␣-cobratoxin binds to both Torpedo (␣1) and ␣7 receptors using some common residues (Trp25, Asp27 and Arg33). In addition, it also uses receptor-specific residues: Ala28, Lys35 and Cys26-Cys30 for recognition of the ␣7 receptor and Lys23 and Lys49 for the Torpedo receptor. Moreover, the cyclic structure formed by the fifth disulphide bridge at the tip of the second loop of ␣-cobratoxin has been reported to be essential for its binding to the ␣7 receptor. 24 Therefore, neurotoxins appear to use a common core of critical residues for binding and additional residues to determine the specificity of their molecular target.
Cardiotoxins
The cytolytic site of cardiotoxins was identified in our laboratory, essentially by a combination of theoretical 44 and chemical modification 45 methods. We had previously predicted the neurotoxic 46 and myotoxic 47 sites in venom phospholipases. Of significance was the finding that the myotoxic site of venom phospholipases and the non-enzymatic myotoxins contained a cationic segment flanking a hydrophobic region. 43 Because myotoxic activity is a reflection of the cytolytic effects of these proteins, we extended this observation to cytolytic regions of proteins from other sources, including bacteria, plants, insects, amphibians, snakes and even humans. Interestingly, all cytolytic proteins, independent of their target cells, showed the presence of hydrophobic and cationic sites flanking each other either in the primary, secondary or tertiary structure. 40 Using this approach, we showed that the cytolytic region in cardiotoxins is spread on all three loops: there is a significant hydrophobic patch extending from the middle to the bottom end of all loops, whereas there is a row of positively charged lysine residues located at the top end (Fig. 3) . We modified the positive charges on lysine residues to negative, neutral and positive charges using chemical methods of succinylation, carbamylation and guanidination, respectively. 41 The native and guanidinated derivative showed cytolytic activity, whereas the succinylated and carbamylated derivatives did not. However, all derivatives showed similar protein folding, as shown by circular dichroism, and retained their ability to bind to phospholipids. 41 These experiments clearly showed the importance of cationic residues for cytolytic activity. In addition, we also oxidized the two methionine residues present in the middle of the hydrophobic segment to methionine sulphoxide, thereby disrupting the hydrophobic site. This derivative failed to show any cytolytic activity and firmly supported the importance of the hydrophobic site in cytolytic region of cardiotoxins (RM Kini and HJ Evans, unpubl. obs., 1989). Our results were corroborated by the demonstration of the role of lysine 48 and methionine 49 residues by monoacetylation and oxidation, respectively. Nuclear magnetic resonance studies indicate that cardiotoxin interacts with phospholipid membranes through its hydrophobic face. 46 
Fig. 2 Molecular determinants of neurotoxins.
Interaction site residues of (a-d) erabutoxin a involved in binding to muscle nicotinic acetylcholine receptors (nAChR) and (e-h) ␣-cobratoxin involved in binding to muscle nAChR (e,f) and neuronal ␣7 nAChR (g,h). Space-filling models of toxins are shown. The residues on the 'concave' surface (a,b) that interacts with nAChR are shown. Corey-Pauling-Koltun (CPK) models (c-h) show the functionally important residues. The molecules are rotated 90° in (d,f,h) to show the surface as seen by the receptor. Site-directed mutation studies were used to determine the residues involved in interaction. The residues shown in white are either not mutated or do not affect the affinity of interaction. The residues in yellow, brown and red, when mutated, decrease the affinity by at least five-, 10-or 100-fold, respectively. For details see Servent et al., 22, 23 Antil-Delbeke et al., 24 Harvey, 2 Pillet et al. 37 and Tremaeau et al.
Acetylcholinesterase inhibitors
The residues constituting the functional site of fasciculin were identified almost simultaneously by two different approaches, namely the generation of synthetic peptides 51 and site-directed mutagenesis. 48 Molecular models of the fasciculin-AChE complex and chemical modification studies suggested a role for the second loop in the interaction of fasciculin with AChE. This was confirmed by a cyclic peptide derivative based on the second loop of fasciculin that inhibited AChE at 15-20 mol/L compared with 300 pmol/L native toxin. 47, 49 Marchot et al., 48 using 14 mutants targeting 16 amino acid residues located in all three loops of fasciculin, identified Thr8, Thr9, Gln11, Arg24, Arg27, His29, Pro30, Pro31 and Met33, which are located in the first and second loops, as being functionally important for interaction with AChE (Fig. 4a,b) . Interestingly, however, this interaction site on fasciculin is located on the opposite surface of the molecule as opposed to the nAChR recognition site in ␣-neurotoxins. 37, 38 More recently, Ricciardi et al. 50 engineered a chimera in which the entire first loop and the tip of the second loop of toxin-␣, a short-chain neurotoxin, was replaced by that of fasciculin 2, together with an Asn61Tyr mutation. This chimera inhibited AChE with a Ki of 680 pmol/L, which was only approximately 15-fold less active than native fasciculin, further highlighting the importance of these segments for the AChE activity.
L-Type calcium channel blockers
By a systematic survey of over 1600 protein-protein interaction sites, we showed that proline residues are most commonly found in the flanking segments of the interaction sites. [51] [52] [53] We proposed that the flanking proline residues protected the integrity and conformation of the interaction site, as well helped in the presentation of the interaction site to the complementary protein. 52, 53 Based on this observation, we developed a simple method for the identification of protein-protein interaction sites directly from the amino acid sequence of a protein. 54 Using this approach, we predicted that the segment between Pro42 and Pro47 was the potential interaction site of calciseptine, FS2 and related toxins 59 ( Fig. 4c,d) . A synthetic 8 mer peptide, namely L-calchin, designed based on this putative interaction site, showed dose-dependent and voltage-independent inhibition of L-type calcium channels in rabbit cardiac myocytes. L-Calchin did not affect the opening and closing kinetics, indicating that it only blocks the L-type calcium channel in a similar manner as the parent toxin. 55 Schleifer, 56 using molecular modelling, also showed that this segment, particularly Met45-Trp46-cisPro46-Tyr47, displayed similar hydrophobic and hydrogen bond-forming properties as nifedipine, a 1,4-dihydropyridine derivative. Therefore, the functional site of L-type calcium channel blockers is located on the outer strand of the third loop of the three-finger scaffold. 
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Platelet aggregation inhibitor
As described previously, the amino acid sequence of dendroaspin (or mambin) contains the Arg-Gly-Asp tripeptide sequence. 15 This tripeptide sequence is flanked by two proline residues and is involved in adhesive function (Fig. 4e,f) . Recently, Lu et al. 57 evaluated the role of the two flanking prolines by substituting both with alanine, with a resulting five-to eightfold loss in the ability to inhibit platelet aggregation. Moreover, Wattam et al. 58 have also replaced the Arg-Gly-Asp sequence by Arg-Tyr-Asp and Arg-CysAsp tripeptide sequences and have demonstrated that these mutations promote selective inhibition of ␤1 and ␤3 integrins, respectively. Thus, the functional site of dendroaspin is located at the tip of its third loop.
Hannalgesin
Hannalgesin, isolated from Ophiophagus hannah (King cobra) venom by our group, exhibited potent analgesic as well as neurotoxic effects in mice. 59 Using the proline bracket method, we identified the functional site of this protein to be located at the carboxy terminal end of the toxin (RM Kini and P Gopalakrishnakone, unpubl. obs., 1996). A short peptide synthesized on the basis of the predicted site showed significant selective analgesic effect in vivo in the absence of neurotoxicity. 60 Thereby, we were able to identify the analgesic site of hannalgesin and isolate and develop the beneficial effect of this toxin.
CONCLUSIONS AND FUTURE PROSPECTS
The compact structure of three-finger proteins has been exploited by nature for developing ligands that perform a wide variety of functions. In elapid and hydrophid snakes, the ancestral gene(s) encoding for three-finger protein(s) were duplicated several times and a wide array of offensive weapons in their armamentarium resulted through accelerated evolution in their exons. [61] [62] [63] During evolution, most features that are essential for protein folding and structural integrity were preserved, leading to 'sibling' toxins that resembled each other in their overall structural features but differed in their missions of targeting various vital physiological processes. This is clearly evident in three-finger toxins, because the core, consisting of the four disulphide bridges, is highly conserved and the functional sites are located on either surface of the molecule on the different loops and/or the carboxy terminal tail. In fact, there is no single designated location for the functional sites. As is the case with other superfamilies of toxins, snakes have used the robust three-finger protein mould to construct a group of toxins with wide variations in function involving just a few subtle changes in the functional sites. This capacity of adaptation no doubt offers them the flexibility to effectively capture any species of prey at their disposal. Their intended interests notwithstanding, snake venom toxins provide us with ample challenging opportunities to decipher the subtleties in their functional sites such that we may better understand the plasticity of protein structure and function. Moreover, they will also tremendously enhance our potential to use their molecular architecture to design and develop mini proteins with novel functions of scientific and therapeutic interest. ) and dendroaspin (e,f). The interaction site of fasciculin is found in loops I and II, whereas that of calciseptine and dendroaspin is found in loop III. The residues involved in interaction are shown as stick models (red) in (a,c,e). Space-filling models of the interaction residues (red) are shown in (b,d,f).
